期刊文献+

冠状动脉迂曲与微血管病变的相关性研究 被引量:5

Relationship between coronary tortuosity and coronary microvascular disease
原文传递
导出
摘要 目的 探讨冠状动脉迂曲与冠状动脉微血管病变(CMVD)之间的相关性.方法 选取2014年6月至2016年12月就诊河北医科大学第二医院心内科的有典型心绞痛症状,行冠状动脉造影未见冠状动脉明显狭窄患者.共入选患者117例,根据静息负荷心肌灌注显像结果,将患者分为CMVD组(69例)和非CMVD组(48例).比较两组患者临床基线资料包括性别、年龄、既往病史、高敏C反应蛋白(hs-CRP)、B型利钠肽、肝肾功能及血脂等,超声心动图参数(左心室射血分数、室间隔和左心室后壁厚度、左心室舒张末内径等)及冠状动脉造影发现冠状动脉迂曲的情况.用logistic回归分析冠状动脉迂曲和CMVD发生的相关性.结果 两组患者在性别、年龄、高血压、血脂异常、高尿酸血症以及既往服用他汀类药物等差异均无统计学意义(P均〉0.05),但CMVD组患者糖尿病发生率高于非CMVD组[78.26%(54/69)比35.42% (17/48),P〈0.001].CMVD组患者hs-CRP[(4.29±2.15) mmol/L比(2.63±1.20) mmol/L,P〈0.001]、低密度脂蛋白胆固醇[(2.98±0.96) mmol/L比(2.52±0.83) mmol/L,P=0.008]和同型半胱氨酸水平[(13.7±5.61) mmol/L比(11.5±4.38)mmol/L,P=0.025]高于非CMVD组,两组患者总胆固醇和甘油三酯水平差异无统计学意义(P均〉0.05).两组患者超声心动图各参数差异无统计学意义(P均〉0.05).冠状动脉造影结果显示,CMVD组冠状动脉计帧数明显大于非CMVD组(左前降支:31.56±4.92比27.31±3.75,左回旋支:29.47±4.18比26.62±3.19,右冠状动脉:29.09±5.05比26.24±3.28,P均〈0.001).CMVD组患者冠状动脉迂曲[60.87% (42/69)比33.33%(16/48),P=0.035]和冠状动脉粥样硬化发生率[76.81%(53/69)比27.08%(13/48),P〈0.001]均大于非CMVD组.logictic回归分析结显示,冠状动脉迂曲(OR=6.111,95%CI 2.707-13.794,P〈0.001)、糖尿病(0R=6.565,95% CI 2.883-14.948,P〈0.001)和冠 Objective To explore the relationship between coronary tortuosity and coronary microvascular disease (CMVD).Methods Patients with typical angina symptoms and without serious coronary artery stenosis by coronary angiography were enrolled from June 2014 to December 2016,and CMVD was diagnosed by single photon emission tomography (SPECT).According to the SPECT results,patients were divided to the CMVD group and non-CMVD group.The baseline clinical characteristics,results of coronary angiography were compared between the two groups.The logistic analysis was used to analyze the relationship between coronary tortuosity and CMVD.Result A total of 117 cases were enrolled,with 69 cases in the CMVD group and 48 cases in the non-CMVD group.No differences were found in gender distribution,age,hypertension,lipid abnormality,hyperuricemia and uses of statins between the two groups (all P〉0.05).Incidence of diabetes (78.26% (54/69) vs.35.42% (17/48),P〈0.05),hs-CRP ((4.29± 2.15)mmol/L vs.(2.63 ± 1.20)mmol/L,P〈0.001),LDL-C ((2.98 ± 0.96)mmol/L vs.(2.52 ±0.83)mmol/L,P=0.008) and homocysteine ((13.7 ± 5.61)mmol/L vs.(11.5 ±4.38)mmol/L,P=0.025) levels were higher in the CMVD group than in the non-CMVD group.The data derived from echocardiographic examination were similar between the two groups.The Corrected TIMI frame counts were higher in the CMVD group than in non-CMVD group (LAD:31.56±4.92 vs.27.31 ±3.75,LCX:29.47±4.18 vs.26.62±3.19,RCA:29.09±5.05 vs.26.24±3.28,all P〈0.001).The incidences of coronary atherosclerosis (76.81%(53/69) vs.27.08%(13/48),P〈0.001) and coronary tortuosity ((60.87% (42/69) vs.33.33% (16/48),P=0.035) were also higher in the CMVD group than in non-CMVD group.Logistic analysis found that coronary tortuosity (OR=6.111,95%CI 2.707-13.794,P〈0.001),diabetes (OR=6.565,95%CI 2.883-14.948,P〈0.001) and coronary atherosclerosis (OR=8.918,95%CI 3.822-20.808,P〈0.001) were independent ri
作者 王志远 汪雁博 郝国贞 姜云发 谷新顺 范卫泽 龚强 王庆 傅向华 Wang Zhiyuan;Wang Yanbo;Hao Guozhen;Jiang Yunfa;Gu Xinshun;Fan Weize;Gong Qiang;Wang Qing;Fu Xianghua.(Department of Cardiology, Second Hospital of Hebei Medical University, Shijiazhuang 0S0000, Chin)
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2018年第5期359-363,共5页 Chinese Journal of Cardiology
关键词 冠状动脉疾病 微血管性心绞痛 冠状动脉造影 体层摄影术 发射型计算机 单光子 Coronary disease Microvascular angina Coronary angiography Tomography emission-computed single-photon
  • 相关文献

参考文献1

二级参考文献10

  • 1Taniyama Y, I to H, Morishita R, et al. Potential of microvascular reperfusion with adjunctive pharmacological intervention: its impact on myocardial perfusion and functional outcomes in patients with acute myocardial infarction[J]. Drugs.2001,61(4) :437 ~ 441. 被引量:1
  • 2Johnson WB, Malone S, Pantely GA, et al. No reflow and extent of infarction during maximal vasodilatation in the porcine heart[J] . Circulation. 1998,78:462 ~ 472. 被引量:1
  • 3Rawitscher D, Levin T, Cohen I, et al. Rapid reversal of no-reflow using abciximab after coronary device intervention[J] .Catheter Cardiovasc Diag. 1997,42:187 ~ 190. 被引量:1
  • 4Pemow J, Wang QD. Endothelin in myocardial ischaemia and reperfusion[J]. Cardiovasc Res. 1997,33:518 ~ 526. 被引量:1
  • 5Golino P, Ragni M, Cirillo P, et al. Recombinant human, active siteblocked factor Ⅶ reduces infarct size and no-reflow phenomenon in atherosclerotic vascular disease[J]. Circulation. 2000,278:1507 ~ 1516. 被引量:1
  • 6Baim D. On behalf of the SAFER investigators: Transcatheter cardiovascular therapeutics meeting[A]. Washington DC. 2000,october. 被引量:1
  • 7Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease[J]. Circulation.2000,101:570- 580. 被引量:1
  • 8Harem CW, Heeschen C, Goldman B, et al. For the CAPTURE investigators. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels[J] . N Engl J Med. 1999, 340:1623- 1629. 被引量:1
  • 9Thorsten R, Robert AK. The "no-reflow" phenomenon: basic science and clinical correlates[J]. Heart. 2002, 87 :162 - 168. 被引量:1
  • 10骆秉铨.冠状动脉无复流现象的临床研究进展[J].中国微循环,2002,6(5):261-264. 被引量:14

共引文献16

同被引文献21

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部